Skip to main content
. 2025 Jun 12;312(3):871–883. doi: 10.1007/s00404-025-08081-9
This study provides the first comprehensive overview of real-world use of RAS for endometriosis in certified centers across Central Europe. It highlights current advantages and barriers, addresses technical and training-related aspects, and identifies specific indications where RAS appears to be favored over CLS. In doing so, it supports clinical decision-making and fosters informed engagement with RAS in the treatment of endometriosis.